FindTrial
Sign In

N/A - Esmeron

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2011-001396-39-DK
Enrollment
Unknown
Registered
2011-05-06
Start date
2011-06-01
Completion date
Unknown
Last updated
2015-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 13.1 Level: LLT Classification code 10049130 Term: Back surgery System Organ Class: 10042613 - Surgical and medical procedures

Interventions

Trade Name: Rocuronium "Hameln" Product Name: Rocuronium "Hameln" Pharmaceutical Form: Solution for injection INN or Proposed INN: ROCURONIUM Concentration unit: mg/ml milligram(s)/millilitre Concentr

Sponsors

Glostrup Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: 0 F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 100 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 50

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s): ;Timepoint(s) of evaluation of this end point: Not applicable—

Secondary

MeasureTime frame
Timepoint(s) of evaluation of this end point: Not applicable—

Countries

Denmark

Contacts

Public ContactKarsten Skovgaard Olsen

Glostrup Hospital

KARSKO01@glo.regionh.dk4538634526

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026